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ABSTRACT 
Background: Percutaneous pulmonary valve implantation (PPVI) using bovine jugular vein 
Melody valve is safe and effective. However, post-procedural complications have been 
reported for unclear reasons.  
Objective: We sought to assess the impact of PPVI procedural steps on valvular histology 
and leaflet mechanical behaviour. 
Methods: Three different valved stents (Melody valve, homemade stents with bovine and 
porcine pericardium) were tested in-vitro in 4 conditions: I) control group, II) crimping, III) 
crimping + inflation of low-pressure balloon and IV) condition III + post dilatation (high-
pressure balloon). For each condition, valvular leaflets (and venous wall sample for Melody 
stents) were taken for histological analysis and mechanical uniaxial tests of valve leaflets.  
Results: Among Melody valves, incidence of transverse fractures was significantly higher in 
traumatized samples compared with control group (p<0.05) whereas, incidence and depth of 
transverse fractures were not statistically different between the 4 conditions for bovine and 
porcine pericardial leaflets. No significant modification in mechanical behaviour of in-vitro 
traumatized Melody® valvular leaflets was observed. Bovine and porcine pericardia became 
more elastic and less resilient after balloon expansion and post-dilatation (condition III and 
IV), with a significant decrease of elastic modulus and stress at rupture. 
Conclusion: Valved stent implantation procedural steps induce histological lesions on 
Melody valve leaflets. Conversely, bovine and porcine pericardial valved stents were not 
histologically altered by in vitro manipulations although their mechanical properties were 
significantly modified. These data could explain some of the long-term complications 
observed with these substitutes.  
 
Keywords: percutaneous valve, pulmonary valve, endocarditis. 
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RESUME 
Introduction: Le remplacement valvulaire pulmonaire percutané utilisant le stent valvé 
Melody est efficace et sécurisé, cependant des endocardites infectieuses surviennent sur ces 
prothèses sans explication évidente. 
But: Evaluer l’impact des manipulations pré-implantatoires sur la structure histologique et le 
comportement mécanique des feuillets valvulaires.  
Méthodes : Nous avons testés in-vitro 3 types de stents valvés (prothèse Melody, stents 
valvés en péricarde bovin et porcin fabriqués manuellement) dans 4 conditions différentes : I) 
groupe témoin ne subissant aucune manipulation, II) sertissage sur un ballonnet III) sertissage 
+ inflation du ballonnet à basse pression, IV) = groupe III + surdilatation par ballonnet à haute 
pression. A l’issu de chaque manipulation les feuillets valvulaires étaient prélevés sur les 
stents puis analysés sur le plan histologique et mécaniques (test de traction uniaxiale). 
Résultats : Pour les valves Melody, on retrouvait plus de lésions histologiques sur les 
feuillets valvulaires dans les groupes II, III et IV par rapport au groupe contrôle (p<0.05). 
L’incidence de ces lésions n’était pas différente entre les 4 conditions pour les stents valvés 
péricardiques. Les propriétés mécaniques des valves Melody traumatisées n’étaient pas 
modifiées. Les péricardes bovin et porcin devenaient plus élastiques et moins résistants dans 
les conditions III et IV, avec une diminution du module d’élasticité et du stress à la rupture.  
Conclusion : Les manipulations réalisées en salle de cathétérisme entraînent des lésions 
histologiques significatives sur les feuillets valvulaires des prothèses Melody. Les stents 
valvés en péricarde bovin et porcin ne sont pas altérés histologiquement par ces manipulations 
mais voient leurs propriétés mécaniques se modifier significativement. Ces données 
pourraient expliquées certaines complications observées à long terme avec ces substituts.  
  
Mots clés: valve percutanée, valve pulmonaire, endocardite 
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List of abbreviations 
RVOT: right ventricular outflow tract  
BJV: Bovine jugular vein  
PPVI: percutaneous pulmonary valve implantation 
IE: infective endocarditis 
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BACKGROUND 
Patients undergoing surgical right ventricular outflow tract (RVOT) reconstruction are subject 
to conduit degeneration later in life, requiring further interventions to alleviate the pulmonary 
stenosis and/or regurgitation that ensue. Since the first reported case in 2000, percutaneous 
pulmonary valve replacement (PPVI) using the Melody® valve (Medtronic Inc, Minneapolis, 
MN, USA) - a glutaraldehyde fixed bovine jugular vein (BJV) valve mounted on a balloon-
expandable stent – is now recognized as an alternative to surgical pulmonary valve 
replacement in patients with failing RVOT [1,2]. Recent reports showed that PPVI was 
feasible at a relatively low risk and mid-term follow-up demonstrated a sustained 
improvement of haemodynamics up to 7 years after implantation [3,4]. Despite these 
promising results, various midterm and long-term complications have been described 
including cases of infective endocarditis (IE) [5-9]. The reported annualized rate of IE ranges 
from 2.4% to 3.9% per patient-year [10,11]. We and others recently showed that IE was more 
frequent after PPVI than surgical pulmonary valve replacement [11,12]. Infective endocarditis 
also involves other valved stents made with different valvular substrates – i.e. Edwards 
Sapien® (Edwards Lifesciences, Irvine, CA) made with bovine pericardium and Corevalve® 
(Medtronic Inc., Minneapolis, Minnesota, USA) made with porcine pericardium [13,14]. 
These results suggest that IE might be related to the implantation technique (i.e percutaneous 
or surgical) that is used for valvular placement. One of the main differences between surgical 
and transcatheter valve replacement is that percutaneous valves undergo several 
manipulations before (i.e. crimping) and during implantation (i.e. balloon expansion) whereas 
surgical prostheses are directly placed in the pulmonary pathway without theoretical valvular 
damage. Traumatic injury to biological valves leaflets has been reported during valved stents 
preparation [15,16]. In a recent work, we demonstrated that selective adhesion of S. aureus 
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and S. sanguinis pathogenic strains was noted on healthy Melody valve tissue and increased 
after implantation procedural steps [17]. 
In this in-vitro study we aimed to assess effects of PPVI procedural steps on histological and 
mechanical properties of Melody® valve leaflets and to compare these results with other 
tissues used for valved stents fabrication (i.e bovine and porcine pericardium). 
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METHODS 
Valvular substrates 
3 types of valved stents were tested experimentally: 
1) The Melody® valve was obtained from Medtronic and stored in its commercial packaging. 
2) Bovine pericardium: valvular leaflets were obtained from a bovine pericardial patch (10 x 
15 cm - Edwards Lifescience, Irvine, USA), cut onto a 21-mm homemade 3 leaflets valvular 
mould and sutured into vascular stent (CP8Z34, Numed Inc, Canada). Valved stents were then 
stored in 0.625% glutaraldehyde until use. 
3) Porcine pericardium: valvular leaflets were obtained from a porcine pericardial patch (8 x 6 
cm - Vascutek Terumo Ltd., Swillington, Leeds). Porcine pericardial valved stents were then 
prepared similarly and stored in 0.625% glutaraldehyde until use. 
 
In-vitro manipulations  
For each valved stent, we compared 4 experimental conditions reproducing the sequential 
procedural steps leading to a conventional PPVI (figure 1). Before manipulation, valved stents 
were rinsed twice for 2 minutes each in 500-ml saline baths to remove glutaraldehyde.  
Condition I: Control group; valved stents were not manipulated.  
Condition II: Compression group; valved stents were manually crimped on sterile syringes (5 
and 2.5-ml) and then onto the 22-mm balloon of the 22-French Ensemble® delivery system 
(figure 1A). The sheath was advanced to cover the balloon-mounted valved stent during 5 
minutes. This duration was chosen arbitrarily and aims to reproduce the crimping duration 
during a conventional PPVI. The compressed prostheses were regularly flushed with a saline 
solution. The sheath was then drawn back and the valved stent was manually enlarged and 
removed avoiding damage on the valve.  
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Condition III: Compression/Expansion group; valved stents were first prepared as in 
condition II. After the sheath was drawn back, valved stents were deployed in a 20-mm 
Goretex conduit by inflation of the inner and outer balloons of the delivery system. The 
balloons were then deflated and the delivery system removed (figure 1A to B).  
Condition IV: Compression/expansion/post-dilatation; valved stents were first prepared as in 
condition III. After valve deployment, a post-dilatation using a 22-mm high-pressure balloon 
(Atlas Gold, Bard Peripheral Vascular, Inc., Tempe, AZ, USA) inflated at 20 ATM for 5 
seconds was performed (figure 1A to C).  
 
Valved stents were analysed in each in-vitro condition for a same substrate. For each 
Melody® valved stent in each condition, 3 additional samples of the BJV wall adjacent to the 
leaflets within sinuses were taken using an 8-mm diameter (i.e. 0.5 cm2) trepan for 
histological tests. After sampling, valvular leaflets and BJV wall fragments were stored in 
0.625% glutaraldehyde until histological processing (within 24 hours) or in a saline solution 
before an immediate mechanical testing (figure 1D).  
For each substrate five leaflets coming from 2 valved stents were studied for histological and 
mechanical evaluation in each of the 4 conditions. 
 
Uniaxial tensile test 
We determined leaflets mechanical properties using uni-axial tensile tests with a universal 
testing machine Adamel Lhomargy MTS 100 (MTS Systems Corporation; Eden Prairie, MN) 
equipped with test TestWorks 4 software (MTS Systems Corporation; Eden Prairie, MN). The 
mechanical properties of native or prosthetic valvular leaflets have been published previously 
with validated methods [18,19]. 
Five leaflets were tested for each substrate in each of the 4 conditions. Tissue thickness was 
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measured with a caliper with a precision of 0.01 mm.  A 100 N load cell was used to apply a 
tensile force to the tissue samples, and the tissue was stretched at a constant rate of 0.5 
mm/min to obtain stress-strain curve on which were recorded stress at break, elongation at 
break, ultimate tensile strength (maximum stress that a material can withstand while being 
stretched before breaking) and elastic modulus (slope of stress–strain curve in the elastic 
deformation region).  
 
Histological analysis 
Macroscopic analysis preceded microscopic evaluation. After paraffin embedding, 5-µm thick 
samples were stained with haematoxylin and eosin (H&E) and digitalized pictures obtained at 
x5 and x20 magnifications. Transverse tissue fracture, the basic lesion previously described 
for bovine pericardial valved stents originated from one surface of the sample deep inside the 
tissue [15].  It was considered as arbitrarily significant when its depth exceeded 25% of 
sample’s thickness. The depth of the biggest fracture was calculated as a percentage 
(fracture’s length/sample thickness). The number of fractures and the depth of the biggest 
fracture were determined at x5 magnification. The pathologist was blinded for the type of in-
vitro manipulation that the sample underwent. 
 
Statistical analysis 
Results were expressed as mean (standard deviation) or median (range) for continuous 
variables or as a number (percent) for categorical variables. The data from these experiments 
were analysed with nonparametric Mann–Whitney or Kruskal-Wallis tests. These tests were 
performed to compare variables between 2 groups (i.e. condition I vs II ; I vs III ; I vs IV ; II 
vs III ; etc.). The value of statistical significance was set at p ≤ 0.05. 
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RESULTS 
Uniaxial tensile tests 
Bovine, porcine and Melody® valve leaflets had a median thickness respectively of 0.57-mm 
(0.45 – 0.7), 0.23-mm (0.18 – 0.25) and 0.1-mm (0.08 – 0.1) and a median width respectively 
of 8-mm (5 – 12), 9-mm (5 – 11) and 6-mm (5-9). Uniaxial measurements showed typical 
non-linear J-shaped stress-strain curves. Table 1 shows the mechanical behaviour of each 
substrate obtained in the different in-vitro conditions. 
No statistical difference was observed for the Melody® valvular leaflets between the 4 
different conditions, for each studied parameter (stress and elongation at break, ultimate 
tensile strength, and elastic modulus). 
Concerning bovine pericardial valved stents, stress at break was significantly lower in 
conditions III and IV compared with control condition (I vs III: p=0.02; I vs IV: p=0.005). 
Elastic modulus was significantly lower in condition III compared to condition I and II (I vs 
III: p=0.042; II vs III: p=0.001). No difference was observed between conditions III and IV 
for elastic modulus values. 
Concerning porcine pericardial valved stents, stress at break and ultimate tensile strength 
were significantly lower in condition IV compared to control condition I (p=0.032 and 0.03 
respectively). Elastic modulus was significantly lower in condition III and IV compared to 
condition I (I vs III: p=0.04; II vs III: p=0.031).  
  
Histological analysis 
No macroscopic lesion such as perforation, tear or laceration of the leaflets (or venous wall 
for Melody® valved stent) was observed, whatever the in-vitro condition was. Microscopic 
analysis revealed presence of transverse fractures in all valvular leaflets (Melody® valve, 
bovine pericardium, porcine pericardium) but not in Melody® BJV wall samples (figure 2 
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and 3). Histological lesions had a heterogeneous distribution. Indeed, areas of healthy tissue 
surrounded areas of severely traumatized tissue within a same leaflet. Except for porcine 
pericardium, transverse fractures were rarely found in samples from control groups (condition 
I). Histological lesions according to substrate and in-vitro conditions are presented in table 2.  
Among Melody® valvular leaflets, the incidence of transverse fractures was significantly 
higher in traumatized samples compared with control group (I vs II: p=0.043; I vs III: 
p=0.043 and I vs IV: p=0.042). No difference was observed between conditions II, III and IV. 
Transverse fractures were significantly deeper in compression group (I vs II: p=0.042). 
Among bovine and porcine pericardial leaflets, the incidence and depth of transverse 
fractures were not statistically different between the 4 in-vitro conditions.  
No histological lesion was observed in BJV wall samples whatever the condition was.  
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DISCUSSION 
The aims of this study were 1) to assess the impact of implantation procedural steps on 
histological structure and mechanical behaviour of the Melody transcatheter pulmonary 
valved stent leaflets and 2) to compare these results with other valvular substrates such as 
bovine and porcine pericardia.  
Among Melody prostheses, we found that procedural steps resulted in significant histological 
lesions from the crimping and compression stage. Conversely, bovine and porcine pericardial 
valved stents were not histologically altered by in vitro manipulations although their 
mechanical properties were significantly modified. 
 
Histological lesions are induced from the early steps of valved stent implantation 
Amahzoune et al. showed that histological lesions such as transverse fractures and 
longitudinal cleavages occurred during crimping and deployment, with more severe injuries 
induced by balloon-expandable valved stents [15]. These results suggested a cumulative 
impact of both crimping and balloon expansion stages on valvular leaflets architecture. Other 
authors observed comparable lesions with bovine pericardial valved stent using various 
techniques of assessment [16-20]. Unlike Amahzoune et al. results, we did not found that 
bovine pericardial leaflets were significantly injured during in vitro manipulations [15]. This 
difference can be explained by the fact that fresh bovine pericardium obtained from a 
slaughterhouse was used in their study while we performed our tests with commercially 
treated and thus possibly more resistant bovine pericardium. Furthermore, the stents were not 
the same in the 2 studies: the platinum and iridium CP8Z34 (NuMED, Inc., Hopkinton, New 
York, USA) stent is more flexible and less sharp than the stainless steel stent used by 
Amahzoune et al. Finally, the fact that we analysed less samples than these authors can 
partially explain the absence of statistically significant results for this substrate. 
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We observed transverse fractures lesions in all traumatized substrates except Melody jugular 
venous wall. In our analysis we did not include the presence of longitudinal cleavages, which 
are possibly non-specific and may correspond to artefacts. We showed that incidence and 
depth of transverse fractures were significantly higher in traumatized samples compared with 
control Melody valvular leaflets group. No difference was observed between conditions II, III 
and IV. Moreover, it is noteworthy that traumatized Melody jugular venous wall was free of 
histological lesions These results suggest that lesions appear from the early implantation 
procedural step (crimping/compression) without cumulative impact of balloon expansion or 
postdilatation. Crushing and shearing of valvular leaflets between the stent on one side and 
the balloon on the other hand during crimping and balloon inflation may explain these lesions. 
Schneider et al. performed an ex-vivo assessment of 9 percutaneously implanted valved 
Melody conduits after surgical explantation by means of histology and immunohistochemistry 
[21]. The authors found that, in the absence of infection, the valve cusps were clinically 
competent and histologically thin and intact. This is not consistent with our findings however, 
the authors did not focus on the presence of transverse fractures. In addition, although 
valvular fractures are induced in the early post-implantation period, in-vivo neo-
endothelialization might be beneficial for these lesions by homogenizing the leaflets surface.  
One could argue that leaflets traumatic injury observed our experiment might theoretically 
lead to an accelerated deterioration of valvular prostheses. Indeed, fractures of collagen 
bundles may create new sites for calcium deposition and thus decrease life duration of the 
valve [22]. However, after a mean implantation time of 3.2 years, Schneider et al. observed a 
complete neo-endothelialization for all specimens without significant pseudointimal 
proliferation, and without calcifications within the valves. To date, there are no published data 
reporting early calcification or degeneration of the Melody valve in the pulmonary position. 
Although early failure of Melody valves implanted within bioprosthetic tricuspid valves has 
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been reported, the pathophysiology of these isolated cases remained unclear [21,23]. 
Furthermore, the mid-term valvular function of the Melody valve is encouraging although 
long-term data are lacking [3,4].  
 
Mechanical behaviour of leaflets after traumatic injury 
Soft biological tissues have specific mechanical properties. Mechanical behaviour is one the 
key characteristics of cardiac valve function. These properties are mainly determined by valve 
tissular architecture and by the balance between extracellular matrix components [24]. 
In our experiment, we found no significant modification in mechanical behaviour of in-vitro 
traumatized Melody® valvular leaflets. However, we can also conclude that BJV leaflets are a 
resilient substrate slightly affected by traumatic injury. Munelly et al. analysed mechanical 
behaviour of bovine pericardium after compression under forces similar to those exerted by 
valved stent crimping. They showed that bovine pericardium was significantly stiffened by 
this process with an increase in elastic modulus [25]. We also found an increase in bovine 
pericardium elastic modulus in our compression group (condition II). Conversely, this 
substrate became more elastic and less resilient after balloon expansion and post-dilatation 
(condition III and IV), with a significant decrease of elastic modulus and stress at rupture.  
Similar results were observed with porcine pericardial stents, the latter becoming more elastic 
and less resilient after balloon expansion and post-dilatation. It is noteworthy that there was 
no difference between conditions III and IV, showing that there was no cumulative impact of 
post-dilatation.  
 
Clinical implications 
Our findings should be analysed in light of published data on incidence and of right-sided 
endocarditis in patients with congenital heart disease after surgery or PPVI. The role played 
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by BJV in endocarditis pathophysiology is concerning. We clearly demonstrated for the first 
time that BJV leaflets were the most histologically altered by in-vitro manipulations. In a 
recent work, we hypothesized that the transverse fractures observed on traumatized leaflets 
might constitute a possible target for bacterial germs to adhere and possibly explain the high 
incidence of IE involving Melody valves [17, 26-28]. However, scanning electron microscopy 
revealed that, bacteria adhered over the entire sample surface in a heterogeneous way. 
Nevertheless, we suggested that histological traumatic lesions might increase surface 
roughness by modifying topographical characteristics of the sample, and thus enable higher 
microbial adhesion [17].  
We showed that incidence of transverse fractures were significantly higher in traumatized 
samples compared with control Melody valvular leaflets group.  No difference was observed 
between conditions II, III and IV. These results suggest that lesions appear from the early 
implantation procedural step (crimping/compression) without cumulative impact of balloon 
expansion or postdilatation. These results highlight the fact that traumatic leaflets lesions 
would not necessarily be avoided by the use of a valve mounted on a self-expanding stent, as 
crimping is also mandatory with such a device.  
Moreover, the usefulness of post-dilation is debated in clinical practice for PPVI. In this 
experiment, we showed that, regardless to the type of valvular substrate, postdilatation was 
not deleterious whether in terms of histological lesions or in terms of mechanical behaviour. 
 It is still unclear whatever the incidence of endocarditis is higher with bovine jugular vein 
compared to pericardium valves in clinical practice. Results of clinical study from Edwards 
pulmonic valve are still missing. However, two points should be taken into account when 
comparing data. First, results from initial US cohort reported only orally by Pr Hijazi ZM in 
various meetings (SCAI 2014, PICS 2014, 2015) showed an incidence of endocarditis of 
3.2% at one year (2 endocarditis over a cohort of 63 patients). Finally, population should be 
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similar when comparing data. Indeed, from unpublished clinical data, included population 
varied greatly between the 2 cohorts. With Melody, patients included tended to have smaller 
conduits with stenotic and pulmonary regurgitation when Edwards patients had mostly large 
unobstructed right ventricular outflow tract. This could artificially decrease the incidence of 
endocarditis as it has been reported that patients with pure pulmonary regurgitation and low 
right ventricular outflow tract gradient after Melody implantation have less endocarditis. 
Larger comparative studies are therefore necessary before drawing any conclusion.   
Limitations 
Our study suffers from limitations. The small number of studied sample in each subgroup 
may have reduced statistical significance of our results. Uniaxial tensile tests were only 
performed in the radial direction of the samples while they are known to have an anisotropic 
behaviour. In our experiment, we induced in vitro acute lesions and our model did not take 
into account the role of cardiac output, pressure gradients and shear stress forces.  
 
CONCLUSION 
Valved stents implantation procedural steps induce Melody® valve leaflets histological 
lesions right from the crimping stage. Conversely, bovine and porcine pericardial valves are 
not significantly altered by procedural manipulations on histological analysis. Mechanical 
properties of Melody® valve leaflets, the thinnest of all, are not altered by these 
manipulations whereas bovine and porcine pericardial valves are significantly modified. This 
could have an impact on long term valvular function and durability of pericardial valve. In the 
other hand, despite reassuring data on mechanical properties with Melody valves, the 
histological lesions observed on traumatized leaflets might constitute a possible target for 
bacterial germs and possibly explain the high incidence of IE involving Melody valves. 
Further experimental studies are warranted to better understand this issue. Results from 
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clinical studies with pericardial valves focusing on endocarditis issue are obviously needed to 
demonstrate any propensity of a tissue over another to infective endocarditis. 
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FIGURE LEGENDS 
Figure 1. Description of in vitro manipulations realised on Melody®  valved stent  
A: Melody® valved stent after saline solution rinsing; B and C: crimping on sterile 5-mL and 
2.5-mL syringes; D: crimping on Ensemble® delivery system ; E: covering of the valved stent 
by the sheath; F: expansion of the valved stent in a 20-mm Goretex conduit ; G: post-
dilatation using high pressure balloon ; H: bovine jugular vein detached from the stent and 
opened on its longitudinal axis, note the 3 valvular leaflets; I: one valvular leaflet after 
sampling. 
 
Figure 2. Histological observation of Melody®  valvular leaflets (H&E staining; x 5 
magnification)  
A: microscopic aspect of a control valvular leaflet (condition I) with a conserved architecture; 
B: microscopic aspect of an injured valvular leaflet (condition III - expansion), note the 
inhomogeneous architecture associated to a large transverse fracture (*). 
 
Figure 3. Histological observation of bovine (A&B) and porcine (C&D) pericardial 
leaflet pericardial leaflets (H&E staining; x 5 magnification)  
A: microscopic aspect of a control bovine pericardial valvular leaflet (condition I) with a 
preserved organization of collagen bundles; B: microscopic aspect of a traumatized bovine 
pericardial valvular leaflet (condition IV – post-dilatation), note the complete architecture 
alteration associated with a large transverse fracture (*); C: microscopic aspect of a control 
porcine pericardial valvular leaflet (condition I) with a slightly altered architecture; D: 
microscopic aspect of an injured porcine pericardial valvular leaflet (condition III - 
expansion), note the presence a large transverse fracture (*). 
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TABLES 
Table 1. Mechanical properties of the different valvular samples 
Melody ® 
Leaflet 
Condition I 
Control 
(n=5) 
Condition II 
Compression 
(n=5) 
Condition 
III 
Expansion 
(n=5) 
Condition IV 
Postdilatation 
(n=5) 
p values 
Stress at break 
(MPa*) 5.7 (2.6-8) 5.7 (2.8-7.9) 
4.6 (3.7-
13) 5.5 (3.7-11.5) 
I vs II, p=0.48 
I vs III, p=0.89 
I vs IV, p=0.87 
II vs III, p=0.66 
II vs IV, p=65 
III vs IV, p=0.79 
Elongation at 
break (%) 34.6 (31-54) 44 (32-49) 66 (19-83) 58 (30-67)  
I vs II, p=0.74 
I vs III, p=0.45 
I vs IV, p=0.38 
II vs III, p=0.48 
II vs IV, p=43 
III vs IV, p=0.7 
Ultimate 
tensile 
strength 
(MPa) 
5.7 (2.7-8.8) 5.6 (2.5-8.9) 5.2 (3.7-13) 5.6 (3.9-11.8) 
I vs II, p=0.64 
I vs III, p=0.68 
I vs IV, p=0.66 
II vs III, p=0.67 
II vs IV, p=0.65 
III vs IV, p=0.79 
Elastic 
modulus 
(MPa) 
0.16 (0.1-
0.4) 
0.19 (0.18-
0.4) 
0.2 (0.16-
0.32) 
0.24 (0.18-
0.31) 
I vs II, p=0.34 
I vs III, p=0.91 
I vs IV, p=0.71 
II vs III, p=0.71 
II vs IV, p=0.90 
III vs IV, p=0.14 
 
Bovine 
pericardium 
Condition I 
Control 
(n=5) 
Condition II 
Compression 
(n=5) 
Condition 
III 
Expansion 
(n=5) 
Condition IV 
Postdilatation 
(n=5) 
p values 
Stress at break 
(MPa) 8.7 (8.2-10) 10.2 (7-12.9) 6 (5-8) 7 (5.7-9.1) 
I vs II, p=0.5 
I vs III, p=0.02 
I vs IV, p=0.005 
II vs III, p=0.18 
II vs IV, p=0.5 
III vs IV, p=0.30 
Elongation at 
break (%) 45 (39-61) 48 (24-60) 
45.8 (40-
49) 42.6 (35-58) 
I vs II, p=0.72 
I vs III, p=0.62 
I vs IV, p=0.58 
II vs III, p=0.84 
II vs IV, p=0.99 
III vs IV, p=0.75 
Ultimate 
tensile 
strength 
(MPa) 
9.7 (6.3-12) 10.7 (7.2-14) 7 (6.3-8.6) 8.4 (6-10.2) 
I vs II, p=0.85 
I vs III, p=0.08 
I vs IV, p=0.13 
II vs III, p=0.14 
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II vs IV, p=0.12 
III vs IV, p=0.37 
Elastic 
modulus 
(MPa) 
0.42 (0.37-
0.54) 
0.52 (0.41-
0.54) 
0.36 50.32-
0.38) 
0.38 (0.33-
0.58) 
I vs II, p=0.33 
I vs III, p=0.042 
I vs IV, p=0.19 
II vs III, p=0.001 
II vs IV, p=0.22 
III vs IV, p=0.43 
 
Porcine 
pericardium 
Condition I 
Control 
(n=5) 
Condition II 
Compression 
(n=5) 
Condition 
III 
Expansion 
(n=5) 
Condition IV 
Postdilatation 
(n=5) 
p values 
Stress at break 
(MPa) 9 (7.5-10.8)  9.4 (7.1-12) 7.6 (2.8-8) 4.9 (1.7-7) 
I vs II, p=0.35 
I vs III, p=0.15 
I vs IV, p=0.032 
II vs III, p=0.06 
II vs IV, p=0.33 
III vs IV, p=0.28 
Elongation at 
break (%) 31 (25-36) 29 (21-37) 36 (32-58) 24 (20-35) 
I vs II, p=0.54 
I vs III, p=0.17 
I vs IV, p=0.25 
II vs III, p=0.17 
II vs IV, p=0.66 
III vs IV, p=0.09 
Ultimate 
tensile 
strength 
(MPa) 
9.2 (7.6-11) 10.5 (7-12) 8.2 (3-8.7) 5 (2-7) 
I vs II, p=0.41 
I vs III, p=0.24 
I vs IV, p=0.03 
II vs III, p=0.12 
II vs IV, p=0.27 
III vs IV, p=0.23 
Elastic 
modulus 
(MPa) 
0.49 (0.4-
0.8) 0.7 (0.36-1) 
0.31 (0.24-
0.44) 
0.43 (0.15-
0.46) 
I vs II, p=0.28 
I vs III, p=0.04 
I vs IV, p=0.031 
II vs III, p=0.35 
II vs IV, p=0.31 
III vs IV, p=0.92 
Median (range), *: Mega-Pascal. 
Table 2. Histological lesions according to substrate and in-vitro conditions. 
Melody®  
Leaflet 
Condition I 
Control 
(n=5) 
Condition II 
Compression 
(n=5) 
Condition 
III 
Expansion 
(n=5) 
Condition IV 
Post 
dilatation 
(n=5) 
p values 
Transverse 
fracture 3 (1-4) 8 (5-18) 11 (5-23) 7 (6-21) 
I vs II, p=0.043 
I vs III, p=0.043 
I vs IV, p=0.042 
II vs III, p=0.71 
II vs IV, p=0.17 
III vs IV, p=0.78 
Deepest fracture  0.4 (0.26-0.93) 0.92 (0.62-1) 
0.68 (0.5-
0.81) 0.87 (0.6-1) 
I vs II, p=0.042 
I vs III, p=0.13 
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I vs IV, p=0.08 
II vs III, p=0.42 
II vs IV, p=0.68 
III vs IV, p=0.13 
 
Bovine 
pericardium 
Condition I 
Control 
(n=5) 
Condition II 
Compression 
(n=5) 
Condition 
III 
Expansion 
(n=5) 
Condition IV 
Post 
dilatation 
(n=5) 
p values 
Transverse 
fracture 0 (0-1) 0 (0-1) 1 (0-6) 0 (0-1) 
I vs II, p=0.31 
I vs III, p=0.18 
I vs IV, p=0.31 
II vs III, p=0.10 
II vs IV, p=1 
III vs IV, p=0.10 
Deepest fracture  0 (0-0.38) 0 (0-0.26) 0.28 (0.26-0.48) 0 (0-0.42) 
I vs II, p=0.14 
I vs III, p=0.14 
I vs IV, p=0.65 
II vs III, p=0.06 
II vs IV, p=0.17 
III vs IV, p=0.14 
 
Porcine 
pericardium 
Condition I 
Control 
(n=5) 
Condition II 
Compression 
(n=5) 
Condition 
III 
Expansion 
(n=5) 
Condition IV 
Postdilatation 
(n=5) 
p values 
Transverse 
fracture 7 (0-9) 2 (0-6) 4 (1-16) 6 (2-8) 
I vs II, p=0.41 
I vs III, p=0.46 
I vs IV, p=0.85 
II vs III, p=0.41 
II vs IV, p=0.08 
III vs IV, p=1 
Deepest 
fracture  0.27 (0-0.86) 0.4 (0-0.68) 
0.48 (0.39-
0.72) 
0.42 (0.38-
0.64) 
I vs II, p=0.68 
I vs III, p=0.34 
I vs IV, p=0.5 
II vs III, p=0.22 
II vs IV, p=0.5 
III vs IV, p=0.06 
 
Median (range); deepest fracture: fracture’s length/sample thickness 
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